{
  "abstract": "In palliative care, we can often predict that a patient is entering a deteriorating phase and the prognosis is limited. We can also anticipate a shift from the oral route to the parental route using continuous subcutaneous infusion (CSCI) as this deterioration progresses. However, how should we appropriately manage medications such as antidepressants that are not amenable to administration by CSCI? Should we proactively deprescribe or dose-reduce such medications to minimise well-recognised issues associated with their abrupt cessation?",
  "authors": [
    {
      "affiliations": [
        "Cork University Hospital, Cork, Ireland",
        "Medicine, Marymount University Hospital and Hospice, Cork, Cork, Ireland"
      ],
      "name": "Karie Dennehy"
    },
    {
      "affiliations": [
        "Pharmacy Department, Marymount University Hospital and Hospice, Cork, Ireland",
        "College of Medicine and Health, University College Cork, Cork, Ireland"
      ],
      "name": "Sarah Marshall"
    }
  ],
  "title": "Deprescribing antidepressant medications at end-of-life",
  "uid": "4afb1a19-3e69-5369-bf69-72fba62e64dd"
}